BioCentury
ARTICLE | Financial News

Cleveland BioLabs adds $15 million

October 20, 2012 12:41 AM UTC

Cleveland BioLabs Inc. (NASDAQ:CBLI) raised $15 million through the sale of 7.5 million units at $2 in a follow-on underwritten by Oppenheimer; Cantor Fitzgerald; and Ladenburg Thalmann. Burrill was financial advisor. Each unit comprises a share and a five-year warrant to purchase 0.5 shares, with each whole warrant exercisable at $3. Cleveland BioLabs was off $0.65 (26%) to $1.83 on Friday. ...